Skip to main content
Premium Trial:

Request an Annual Quote

Marina Publishes Animal Data on Liposomal Delivery System


Marina Biotech this week announced that it has published preclinical data showing the use of its DiLA2 liposomal delivery technology for systemic administration of siRNAs against a number of liver targets.

According to the paper, which appeared in Molecular Therapy, one formulation resulted in greater than 80 percent knockdown of apolipoprotein B, transthyretin, factor VII, and proprotein convertase subtilisin/kexin type 9 mRNA when administered systemically in a 2 mg/kg dose to animal models.

“The formulation was well tolerated with single- and multiple-dose regimens,” Marina said. “Additionally, when stored frozen, DiLA2-based formulations demonstrated physical and chemical stability for greater than one year.”

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.